ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
45 announcements with these filters
Godrej Agrovet submitted its Annual Secretarial Compliance Report for FY 2025-26. The report notes an administrative warning from SEBI regarding historical shareholding disclosure delays.
Godrej Agrovet delivered a strong Q4 FY26 with 9% revenue growth and 16.8% PBT growth. The company surpassed the ₹10,000 crore annual revenue milestone with improved margins.
Godrej Agrovet surpassed ₹10,000 Cr revenue in FY26, achieving record profitability driven by 68% EBIT growth in Oil Palm and sustained Animal Nutrition volumes, despite challenges in Dairy and Crop Care.
Godrej Agrovet surpassed ₹10,000 Cr revenue in FY26 with all-time high profitability. Strong performance in Oil Palm and Animal Nutrition offset headwinds in Dairy and Crop Care.
Godrej Agrovet surpassed ₹10,000 Cr revenue in FY26 with record profitability. Growth driven by Oil Palm and Animal Nutrition segments, offsetting challenges in Dairy and Crop Care.
Godrej Agrovet Ltd reported consolidated revenue of ₹10,233 Crore for FY26, a 9% year-on-year increase. Profit before tax (excluding exceptional items) grew 17% to ₹569 Crore. Strong performance was driven by the Oil Palm and Animal Nutrition segments, while Astec LifeSciences achieved an EBITDA turnaround. The company also improved its sustainability footprint and ROCE.
Godrej Agrovet Limited has recommended a final dividend of ₹11 per equity share for the financial year 2025-26. The record date is set for July 29, 2026, with payment expected by August 10, 2026, subject to shareholder approval at the upcoming AGM on August 5, 2026.
Godrej Agrovet Limited allotted 30,973 equity shares under its ESOP/ESPS scheme on April 30, 2026. This increases the company's paid-up share capital from ₹192.33 Crore to ₹192.36 Crore. Such allotments are routine corporate actions for employee compensation and retention.
Godrej Agrovet Ltd reported revenue from operations of ₹2,333 Cr (+9.3% YoY) and net profit of ₹102.3 Cr (+54.8% YoY) for Q4 FY26.
Godrej Agrovet Limited reported consolidated annual revenue of ₹10,232.68 Crore and profit of ₹445.18 Crore for FY26. The Board recommended a final dividend of 110% (₹11 per share) and approved the allotment of 30,973 equity shares under its employee stock grant scheme.
Godrej Agrovet Limited shareholders approved the re-appointment of Dr. Ashok Gulati as an Independent Director. His second term commences on May 7, 2026, and extends until May 10, 2029.
Godrej Agrovet Limited has re-appointed Mr. Ashok Gulati as a Non-Executive Independent Director for a second term of 36 months, effective from May 7, 2026.
Godrej Agrovet Limited announced the successful passage of a special resolution via postal ballot for the re-appointment of Dr. Ashok Gulati as an Independent Director. The resolution was passed with a 99.98% majority on April 27, 2026.
Godrej Agrovet announced a leadership succession: Nadir Godrej will retire as Chairman on August 13, 2026. Burjis Godrej, currently Executive Director, will take over as Chairperson and Non-Executive Director effective August 14, 2026. This planned transition ensures continuity within the company's senior management and board leadership.
Godrej Agrovet's Board approved the retirement of Mr. Nadir Godrej as Chairman and Non-Executive Director effective August 13, 2026. Mr. Burjis N. Godrej will succeed him as Chairperson from August 14, 2026, and serves as Chairman-Designate effective immediately. Mr. Nadir Godrej was also appointed as Chairman Emeritus effective August 14, 2026.